VTRS
Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum-inputs (vergelijkbare managers):
breedte van houders -13.6% ·
aandelenstroom +6.8% ·
netto nieuwe posities -15.8%
— formule
Geconcentreerde accumulatie — stijgende aandelen bij minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 150 | -1 | 757.40M | $12.03B | +6 | −6 |
| Q1 2026 | 153 | +6 | 683.49M | $9.23B | +9 | −4 |
| Q4 2025 | 146 | -3 | 743.40M | $9.25B | +1 | −3 |
| Q3 2025 | 22 | -3 | 488.65M | $4.84B | — | −4 |
| Q2 2025 | 23 | +2 | 455.87M | $4.07B | +3 | −1 |
| Q1 2025 | 18 | -1 | 210.93M | $1.84B | +1 | −2 |
| Q4 2024 | 19 | -3 | 200.96M | $2.50B | +1 | −4 |
| Q3 2024 | 21 | +3 | 124.36M | $1.44B | +3 | — |
| Q2 2024 | 18 | — | 121.66M | $1.29B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 63.75M | — | $793.65M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 58.68M | +20.3% | $730.56M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | Geode Capital Management ✦ (passief) | 30.07M | +2.1% | $373.41M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (passief) | 11.45M | +3.4% | $142.59M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 9.96M | +135.8% | $123.96M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 6 | Glenview Capital ✦ | 9.32M | +23.1% | $116.08M | 2.9% | ▲ Add | 3 | SEC ↗ |
| 7 | Greenlight Capital (DME Capital) ✦ | 5.79M | -20.4% | $72.02M | 3.7% | ▼ Trim | 3 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 3.77M | -38.8% | $46.89M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Bridgewater Associates ✦ | 2.29M | +71.4% | $28.56M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 1.88M | -13.3% | $23.47M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 11 | Gotham Asset Management ✦ | 1.52M | +14.6% | $18.92M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 1.17M | +2170.0% | $14.59M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 13 | Adage Capital Partners ✦ | 516.36K | Nieuw | $6.43M | 0.0% | New | 1 | SEC ↗ |
| 14 | GAMCO Investors ✦ | 303.12K | -3.5% | $3.77M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 162.60K | -67.6% | $2.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 133.62K | -82.7% | $1.66M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 17 | Capital World Investors ✦ | 110.68K | 0.0% | $1.38M | 0.0% | Held | 3 | SEC ↗ |
| 18 | Wellington Management ✦ | 68.15K | +10.1% | $848,442 | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 19 | Fisher Asset Management ✦ | 16.72K | +32.8% | $208,195 | 0.0% | ▲ Add | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Adage Capital Partners | $6.43M | 0.0% |
Verlaten
| Arrowstreet Capital | $29.83M | was 0.0% |
| Renaissance Technologies | $3.50M | was 0.0% |
| Point72 Asset Management | $3.48M | was 0.0% |
| Soros Fund Management | $118,828 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,011 houders, 984.50M aandelen, $12.02B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.